share_log

EDAP TMS Publishes HIFI Study Results In European Urology

デダップtmsが欧州泌尿器科におけるHIFI研究結果を発表

Benzinga ·  12/04 22:12
  • HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatments
  • Positive study results are expected to drive further adoption of Focal One as a first line treatment option for the management of localized prostate cancer
  • Study shows Focal One Robotic HIFU is non-inferior to surgery, meeting primary endpoint of non-inferiority for Salvage Treatment-free Survival (STFS) after High Intensity Focused Ultrasounds (HIFU) compared to Radical Prostatectomy (RP) at 30 months
  • Study shows that patients receiving HIFU had better outcomes with respect to urinary continence and erectile function compared to patients receiving RP
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする